Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
1 Day Agoview on linkedin
A newly developed molecular predictor has the potential to identify patients with melanoma who could benefit from treatment with checkpoint inhibitors. The method incorporates the gene-expression features of spontaneous regression to determine which patients with late-stage melanoma would most likely respond well to targeted antibodies. Learn more via Cancer Therapy Advisor: https://lnkd.in/dueCzit
1 Day Agoview on linkedin
Cambridge Healthtech Institute’s Immunogenicity & Bioassay Summit will bring scientists together to discuss the latest challenges facing the bioanalytical industry. Interested in attending? There is still time to register and join our team in Washington D.C. on October 22-25. https://lnkd.in/dtUnF_8
4 Days Agoview on linkedin
As a Principal Investigator with BioAgilytix, you’ll have the opportunity to develop and validate biomarker, cell-based, immunogenicity, immuno- and enzymatic assays to support of innovative drug development projects. Apply today: https://lnkd.in/eW-zg5X
September 19, 2018A Dose of Pharma and Biotech News: September 19, 2018
September 12, 2018New Research on the Diagnostic Journey of Patients with Ankylosing Spondylitis
September 18, 2018BioAgilytix Announces Extensive Facilities Expansion Plan at Its USA Headquarters
August 15, 2018BioAgilytix Named to Inc. Magazine’s Inc. 5000 List of Fastest-Growing Private U.S. Companies for Fifth Time
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
